Skip to content

Quantification of Cerebral Perfusion by Contrast-enhanced Ultrasound During Neonatal Heart Surgery

Quantifizierung Der Hirnperfusion Während Kinderherzchirurgischer Operationen Durch Transkraniellen Kontrastmittelverstärkten Ultraschall

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03215628
Acronym
TCEUS
Enrollment
12
Registered
2017-07-12
Start date
2017-07-04
Completion date
2021-08-30
Last updated
2021-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Defects, Congenital

Keywords

CEUS, TCEUS, contrast enhanced ultrasound, perfusion, cerebral perfusion, sulphur hexafluoride, SonoVue

Brief summary

Transcranial contrast-enhanced ultrasound for evaluation of cerebral blood flow during pediatric cardiac surgery. This study is aimed as a feasibility study prior to conducting a lager prospective clinical trial including neurologic and developmental outcome measures.

Detailed description

The cerebral perfusion of infants with congenital heart defects is a critical determinant during cardiac surgery. The majority of these interventions is performed during deep or moderate hypothermia (25-32°C) with reduced blood flow of the heart-lung-machine (HLM). Assuming a symmetrical anatomy of the cerebral arteries (C. Willisii) a single vessel (T. brachiocephalicus) is then supplying the cerebral blood flow. Using contrast-enhanced ultrasound the cerebral blood flow will be assessed during cardiac surgery interventions.

Interventions

DIAGNOSTIC_TESTTCEUS

Intravenous sulphur hexafluoride microbubbles

Sponsors

University of Erlangen-Nürnberg Medical School
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 4 Months
Healthy volunteers
No

Inclusion criteria

* Neonates and infants ≤ 4 month (open fontanelle) * Proper ultrasound conditions/window * Appropriate general and neurologic state of health * Written consent of both parents/guardians * Availability of trained sonographer (medical doctor)

Exclusion criteria

* Absence of trained sonographer (medical doctor) * Intolerance against SonoVue® (bzw. sulphur hexafluoride) * Missing signed consent * Reduced or inappropriate general and neurologic state of health * Preexisting cerebral injury

Design outcomes

Primary

MeasureTime frameDescription
Relative Blood Flow (RBF)Intraoperative (Directly after start of surgical intervention (T1) vs. Directly before end of intervention (T5))Relative/percentage difference of cerebral perfusion by TCEUS-based quantification using VueBox(R) software
Time-To-Peak (TTP)Intraoperative (Directly after start of surgical intervention (T1) vs. Directly before end of intervention (T5))Relative/percentage difference of cerebral perfusion by TCEUS-based quantification using VueBox(R) software
Mean-Transit-Time (MTT)Intraoperative (Directly after start of surgical intervention (T1) vs. Directly before end of intervention (T5))Relative/percentage difference of cerebral perfusion by TCEUS-based quantification using VueBox(R) software
Maximum Intensity (MI)Intraoperative (Directly after start of surgical intervention (T1) vs. Directly before end of intervention (T5))Relative/percentage difference of cerebral perfusion by TCEUS-based quantification using VueBox(R) software
Relative Blood Volume (RBV)Intraoperative (Directly after start of surgical intervention (T1) vs. Directly before end of intervention (T5))Relative/percentage difference of cerebral perfusion by TCEUS-based quantification using VueBox(R) software

Secondary

MeasureTime frameDescription
Time-To-Peak (TTP)Directly after start of surgical intervention (T1) vs. Directly after full flow of HLM at 37°C (T2)Relative/percentage difference of cerebral perfusion by TCEUS-based quantification using VueBox(R) software
Mean-Transit-Time (MTT)Directly after start of surgical intervention (T1) vs. Directly after full flow of HLM at 37°C (T2)Relative/percentage difference of cerebral perfusion by TCEUS-based quantification using VueBox(R) software
Maximum Intensity (MI)Directly after start of surgical intervention (T1) vs. Directly after full flow of HLM at 37°C (T2)Relative/percentage difference of cerebral perfusion by TCEUS-based quantification using VueBox(R) software
Relative Blood Volume (RBV)Directly after start of surgical intervention (T1) vs. Directly after full flow of HLM at 37°C (T2)Relative/percentage difference of cerebral perfusion by TCEUS-based quantification using VueBox(R) software
Relative Blood Flow (RBF)Directly after start of surgical intervention (T1) vs. Directly after full flow of HLM at 37°C (T2)Relative/percentage difference of cerebral perfusion by TCEUS-based quantification using VueBox(R) software

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026